Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

GSK2194069

Catalog No. T15429Cas No. 1332331-08-4

GSK2194069 is an active β-keto reductase (KR)-specific inhibitor of fatty acid synthase (FASN) with an IC50 of 7.7 nM in an assay for the detection of released CoA.GSK2194069 inhibits the proliferation of FAS in cancer cells through the action of acetoacetyl-coenzyme A and NADPH.

GSK2194069

GSK2194069

Purity: 99.84%
Catalog No. T15429Cas No. 1332331-08-4
GSK2194069 is an active β-keto reductase (KR)-specific inhibitor of fatty acid synthase (FASN) with an IC50 of 7.7 nM in an assay for the detection of released CoA.GSK2194069 inhibits the proliferation of FAS in cancer cells through the action of acetoacetyl-coenzyme A and NADPH.
Pack SizePriceAvailabilityQuantity
2 mg$149In Stock
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Purity:99.84%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
GSK2194069 is an active β-keto reductase (KR)-specific inhibitor of fatty acid synthase (FASN) with an IC50 of 7.7 nM in an assay for the detection of released CoA.GSK2194069 inhibits the proliferation of FAS in cancer cells through the action of acetoacetyl-coenzyme A and NADPH.
Targets&IC50
β-ketoyl reductase:7.7 nM, Phosphatidylcholine:15.5 ± 9 nM(EC50)
In vitro
GSK2194069 (100 nM; 24 h) suppresses fatty acid synthase (FAS) activity in cancer cell lines (KATO-III, MKN45, A549, SNU-1) while maintaining FAS protein production levels.[1] GSK2194069 (5 μM and 20 μM) demonstrates higher efficacy in FASN-positive LNCaP cells compared to FASN-negative PC3 cells, correlating with higher FASN expression in LNCaP cells.[2] GSK2194069 (50 μM; 24 h) inhibits the growth of LNCaP-LN3 human prostate cancer cells.[3] GSK2194069 (60.4 nM; 24 h) exhibits metabolomic alterations, including decreases in L-acetyl carnitine, stearoyl carnitine, vaccenyl carnitine, and palmitoyl-L-carnitine in LNCaP-LN3 cells.[3]
Chemical Properties
Molecular Weight428.48
FormulaC25H24N4O3
Cas No.1332331-08-4
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 90.0 mg/mL (210.0 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.3338 mL11.6692 mL23.3383 mL116.6916 mL
5 mM0.4668 mL2.3338 mL4.6677 mL23.3383 mL
10 mM0.2334 mL1.1669 mL2.3338 mL11.6692 mL
20 mM0.1167 mL0.5835 mL1.1669 mL5.8346 mL
50 mM0.0467 mL0.2334 mL0.4668 mL2.3338 mL
100 mM0.0233 mL0.1167 mL0.2334 mL1.1669 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy GSK2194069 | purchase GSK2194069 | GSK2194069 cost | order GSK2194069 | GSK2194069 chemical structure | GSK2194069 in vitro | GSK2194069 formula | GSK2194069 molecular weight